BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 27444927)

  • 21. Utilization of breast cancer screening with magnetic resonance imaging in community practice.
    Hill DA; Haas JS; Wellman R; Hubbard RA; Lee CI; Alford-Teaster J; Wernli KJ; Henderson LM; Stout NK; Tosteson ANA; Kerlikowske K; Onega T
    J Gen Intern Med; 2018 Mar; 33(3):275-283. PubMed ID: 29214373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Supplemental MRI Screening for Women with Extremely Dense Breast Tissue.
    Bakker MF; de Lange SV; Pijnappel RM; Mann RM; Peeters PHM; Monninkhof EM; Emaus MJ; Loo CE; Bisschops RHC; Lobbes MBI; de Jong MDF; Duvivier KM; Veltman J; Karssemeijer N; de Koning HJ; van Diest PJ; Mali WPTM; van den Bosch MAAJ; Veldhuis WB; van Gils CH;
    N Engl J Med; 2019 Nov; 381(22):2091-2102. PubMed ID: 31774954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mammographic screening in women at increased risk of breast cancer after treatment of Hodgkin's disease.
    Kwong A; Hancock SL; Bloom JR; Pal S; Birdwell RL; Mariscal C; Ikeda DM
    Breast J; 2008; 14(1):39-48. PubMed ID: 18186864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
    Pediconi F; Catalano C; Roselli A; Padula S; Altomari F; Moriconi E; Pronio AM; Kirchin MA; Passariello R
    Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41.
    Hooley RJ; Greenberg KL; Stackhouse RM; Geisel JL; Butler RS; Philpotts LE
    Radiology; 2012 Oct; 265(1):59-69. PubMed ID: 22723501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk.
    Berg WA; Zhang Z; Lehrer D; Jong RA; Pisano ED; Barr RG; Böhm-Vélez M; Mahoney MC; Evans WP; Larsen LH; Morton MJ; Mendelson EB; Farria DM; Cormack JB; Marques HS; Adams A; Yeh NM; Gabrielli G;
    JAMA; 2012 Apr; 307(13):1394-404. PubMed ID: 22474203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast MRI as an adjunct to mammography: Does it really suffer from low specificity? A retrospective analysis stratified by mammographic BI-RADS classes.
    Benndorf M; Baltzer PA; Vag T; Gajda M; Runnebaum IB; Kaiser WA
    Acta Radiol; 2010 Sep; 51(7):715-21. PubMed ID: 20707656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic development of an abbreviated protocol for screening breast magnetic resonance imaging.
    Strahle DA; Pathak DR; Sierra A; Saha S; Strahle C; Devisetty K
    Breast Cancer Res Treat; 2017 Apr; 162(2):283-295. PubMed ID: 28138893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
    Uematsu T; Yuen S; Kasami M; Uchida Y
    Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whole-breast US following mammography and breast MRI in newly diagnosed breast cancer patients: can it be more than just a guidance tool for biopsy?
    Park YJ; Kim MJ; Moon HJ; Kim EK; Yoon JH
    Clin Radiol; 2017 May; 72(5):425.e1-425.e7. PubMed ID: 27712905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer.
    Kriege M; Brekelmans CT; Obdeijn IM; Boetes C; Zonderland HM; Muller SH; Kok T; Manoliu RA; Besnard AP; Tilanus-Linthorst MM; Seynaeve C; Bartels CC; Kaas R; Meijer S; Oosterwijk JC; Hoogerbrugge N; Tollenaar RA; Rutgers EJ; de Koning HJ; Klijn JG
    Breast Cancer Res Treat; 2006 Nov; 100(1):109-19. PubMed ID: 16791481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of Risk Category and Screening Round on the Performance of an MR Imaging and Mammography Screening Program in Carriers of the BRCA Mutation and Other Women at Increased Risk.
    Vreemann S; Gubern-Mérida A; Schlooz-Vries MS; Bult P; van Gils CH; Hoogerbrugge N; Karssemeijer N; Mann RM
    Radiology; 2018 Feb; 286(2):443-451. PubMed ID: 29040037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effectiveness of positron emission mammography and MRI in the contralateral breast of women with newly diagnosed breast cancer.
    Berg WA; Madsen KS; Schilling K; Tartar M; Pisano ED; Larsen LH; Narayanan D; Kalinyak JE
    AJR Am J Roentgenol; 2012 Jan; 198(1):219-32. PubMed ID: 22194501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Why Start Now? Retrospective Study Evaluating Baseline Screening Mammography in Patients Age 60 and Older.
    Chieh AY; Willis JG; Carroll CM; Mobley AA; Li Y; Li M; Woodard S
    Curr Probl Diagn Radiol; 2024; 53(1):62-67. PubMed ID: 37704485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer.
    Lord SJ; Lei W; Craft P; Cawson JN; Morris I; Walleser S; Griffiths A; Parker S; Houssami N
    Eur J Cancer; 2007 Sep; 43(13):1905-17. PubMed ID: 17681781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer.
    Stoutjesdijk MJ; Boetes C; Jager GJ; Beex L; Bult P; Hendriks JH; Laheij RJ; Massuger L; van Die LE; Wobbes T; Barentsz JO
    J Natl Cancer Inst; 2001 Jul; 93(14):1095-102. PubMed ID: 11459871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma.
    Ng AK; Garber JE; Diller LR; Birdwell RL; Feng Y; Neuberg DS; Silver B; Fisher DC; Marcus KJ; Mauch PM
    J Clin Oncol; 2013 Jun; 31(18):2282-8. PubMed ID: 23610104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maximum intensity breast diffusion MRI for BI-RADS 4 lesions detected on X-ray mammography.
    Bickelhaupt S; Paech D; Laun FB; Steudle F; Kuder TA; Mlynarska A; Bach M; Lederer W; Teiner S; Schneider S; Ladd ME; Daniel H; Stieber A; Kopp-Schneider A; Delorme S; Schlemmer HP
    Clin Radiol; 2017 Oct; 72(10):900.e1-900.e8. PubMed ID: 28687167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial.
    Kuhl C; Weigel S; Schrading S; Arand B; Bieling H; König R; Tombach B; Leutner C; Rieber-Brambs A; Nordhoff D; Heindel W; Reiser M; Schild HH
    J Clin Oncol; 2010 Mar; 28(9):1450-7. PubMed ID: 20177029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.